Drug or treatment

Omalizumab clinical trials

• 10Clinical trials
• 6Countries

Newest trials

All recruiting trials (10)

• Oral Food Challenge After Starting Omalizumab in Food Allergy

  This trial tests whether omalizumab begins to help with food allergy within 2 to 4 weeks after starting treatment in people with a confirmed food allergy.

  Recruiting Phase 4 Johns Hopkins University · Baltimore, Maryland · NCT07845552

• Severe chronic urticaria not responding to high-dose omalizumab in France

  This study looks at adults with chronic spontaneous or inducible urticaria who don’t respond to optimized omalizumab to see what factors are linked to non-response and what other options people use.

  Recruiting Centre Hospitalier Universitaire de Besancon · Besançon, Franche-comté · NCT07833696

• Remibrutinib and omalizumab-based treatment approach for adults with chronic spontaneous urticaria not well controlled by antihistamines

  This trial tests a sequencing plan using remibrutinib and omalizumab to see if it helps adults with chronic spontaneous urticaria that isn’t well controlled by second-generation antihistamines.

  Recruiting at 10 sites Phase 3 Novartis · London, Ontario and 9 other locations · NCT07816328

• Switching to Omlyclo® (omalizumab biosimilar) for adults with chronic spontaneous urticaria or severe allergic asthma

  This will try switching adults who are stable on reference omalizumab to the biosimilar Omlyclo® to see if disease control and patient satisfaction stay the same over 12 months.

  Recruiting Celltrion HealthCare France · Montpellier · NCT07425639

• Omalizumab for people with COPD who are allergic to common indoor allergens

  This trial will test whether monthly injections of omalizumab (Xolair) help people aged 40+ with COPD who are allergic to and exposed to common indoor allergens reduce symptoms or exacerbations.

  Recruiting at 10 sites Phase 2 Johns Hopkins University · Birmingham, Alabama and 22 other locations · NCT07059091

• Omalizumab given by weight for food allergy

  This study will test whether higher, weight-based doses of omalizumab are safe and help people with food allergies, including those with very high allergic antibody (IgE) levels, tolerate their allergens better.

  Recruiting at 3 sites Phase 2 Massachusetts General Hospital · Boston, Massachusetts and 2 other locations · NCT06943534

• Omalizumab to increase tolerance to common food allergens in people with high total IgE

  This trial will test whether omalizumab injections every two weeks for 24 weeks, with an optional 8-week twice-weekly extension, can help people with food allergies and very high total IgE tolerate allergic foods.

  Recruiting Phase 2 Johns Hopkins University · Baltimore, Maryland · NCT06934200

• Evaluating Omalizumab's Effect on Skin in Food Allergy Patients

  This study is testing if the medication omalizumab can improve skin problems in people with food allergies and help reduce their allergic reactions.

  Recruiting Phase 4 National Jewish Health · Denver, Colorado · NCT06618963

• Using omalizumab to prevent asthma exacerbations in children

  This study is testing if a single dose of omalizumab can help children aged 6-17 with asthma avoid worsening symptoms during colds and infections.

  Recruiting Phase 2 Children's National Research Institute · Washington D.C., District of Columbia · NCT05332067

• Shortening Omalizumab Treatment for Severe Asthma

  This study is testing if people with well-controlled severe allergic asthma can stop taking the medication Omalizumab after a long time and still keep their asthma under control.

  Recruiting Phase 4 Assistance Publique - Hôpitaux de Paris · Paris, Île-de-France Region · NCT04763447

Quick answers

How many clinical trials of Omalizumab are recruiting right now?

10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 6 countries. The most sites are in United States (6 trials), France (3 trials), Canada (1 trial), Hong Kong (1 trial), Japan (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 4, Phase 4: 3, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →